Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
|
STREAMLINE HEALTH SOLUTIONS INC. (Name of Issuer) |
Common Stock, $0.01 par value (Title of Class of Securities) |
86323X106 (CUSIP Number) |
Gerrit van der Zwan 808 SE Chkalov Drive, Suite 3-322 Vancouver, WA, 98683 360-737-4153 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
11/13/2024 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 86323X106 |
| 1 |
Name of reporting person
Tamarack Advisers, LP | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
92,294.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
2.2 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
HC |
SCHEDULE 13D
|
| CUSIP No. | 86323X106 |
| 1 |
Name of reporting person
Ferayorni Justin John | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
154,044.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
3.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 86323X106 |
| 1 |
Name of reporting person
Tamarack Capital GP, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
92,294.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
2.2 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
HC |
SCHEDULE 13D
|
| CUSIP No. | 86323X106 |
| 1 |
Name of reporting person
Tamarack Capital Management, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
OO |
SCHEDULE 13D
|
| CUSIP No. | 86323X106 |
| 1 |
Name of reporting person
Tamarack Global Healthcare Fund, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock, $0.01 par value |
| (b) | Name of Issuer:
STREAMLINE HEALTH SOLUTIONS INC. |
| (c) | Address of Issuer's Principal Executive Offices:
2400 OLD MILTON PARKWAY, BOX 1353, ALPHARETTA,
GEORGIA
, 30009. |
| Item 2. | Identity and Background |
| (a) | Mr. Ferayorni, a United States Citizen.Tamarack Capital GP, LLC, a Delaware limited liability companyTamarack Advisers, LP, a Delaware limited partnershipTamarack Capital Management, LLC, a Delaware limited liability companyTamarack Global Healthcare Fund, L.P., a Delaware limited partnership |
| (b) | 300 Carlsbad Village Drive, Suite 108A-228, Carlsbad, CA 92008 |
| (c) | Mr. Ferayorni's principal occupation or employment is the managing member of a holding company located at the address listed above.The other entities are wholly owned by either Mr. Ferayorni, or other entities that are controlled by Mr. Ferayorni. |
| (d) | Neither Mr. Ferayorni, nor any of the other reporting entities, has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors.) |
| (e) | Neither Mr. Ferayorni , nor any of the other reporting entities, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| (f) | Mr. Ferayorni, a United States Citizen.Tamarack Capital GP, LLC, a Delaware limited liability companyTamarack Advisers, LP, a Delaware limited partnershipTamarack Capital Management, LLC, a Delaware limited liability companyTamarack Global Healthcare Fund, L.P., a Delaware limited partnership |
| Item 3. | Source and Amount of Funds or Other Consideration |
Not Applicable | |
| Item 4. | Purpose of Transaction |
The distribution of the stock held in the account of Tamarack Global Healthcare Fund, L.P. was performed because the private funds ceased operations. The number of shares reported differs from the previous Schedule D because of a reverse spilt on 15:1. | |
| Item 5. | Interest in Securities of the Issuer |
| (a) | Reference is made hereby to Items 7-11 and 13 of the Cover Page Reporting Person information of this Schedule, which Items are incorporated by reference herein. The calculation of percentage of beneficial ownership in the items 13 were derived from the Issuer?s provided number of shares of Common Stock outstanding after the reverse split of 15:1. |
| (b) | Reference is made hereby to Items 7-11 and 13 of the Cover Page Reporting Person information of this Schedule, which Items are incorporated by reference herein. The calculation of percentage of beneficial ownership in the items 13 were derived from the Issuer?s provided number of shares of Common Stock outstanding after the reverse split of 15:1. |
| (c) | The following shares were transferred in-kind from Tamarack Global Healthcare Fund, L.P. and an additional fund managed by Tamarack Advisers, LP to the partners of those funds. 92,294 of those transferred shares were allotted to entities under control of Mr. Ferayorni,Date #of shares Price---------------- ------------------ $-------------11/13/2024 328,724 0.00 |
| (d) | Other than Mr. Ferayorni and the owners of the family accounts managed by Mr. Ferayorni, no person has the right to receive, or the power to direct the receipt of dividends from, or the proceeds from, the sale of, the common stock mentioned in item 1. |
| (e) | 11/13/2024 |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
None | |
| Item 7. | Material to be Filed as Exhibits. |
None |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
|
|